Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia | |
Chang, Lung-Ji; Dong, Lujia; Guo, Hao-Hsiang; Zhang, Jian-Ping; Gao, Zhi-Yung; Li, Wei-Da; Cui, Jiuwei; Li, Wei; Lu, Daopei | |
刊名 | MOLECULAR THERAPY
![]() |
2014 | |
卷号 | 22 |
ISSN号 | 1525-0016 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3546814 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Chang, Lung-Ji,Dong, Lujia,Guo, Hao-Hsiang,et al. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia[J]. MOLECULAR THERAPY,2014,22. |
APA | Chang, Lung-Ji.,Dong, Lujia.,Guo, Hao-Hsiang.,Zhang, Jian-Ping.,Gao, Zhi-Yung.,...&Lu, Daopei.(2014).Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia.MOLECULAR THERAPY,22. |
MLA | Chang, Lung-Ji,et al."Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia".MOLECULAR THERAPY 22(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论